{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T03:12:36Z","timestamp":1772680356009,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:00:00Z","timestamp":1567555200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:00:00Z","timestamp":1567555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1175-5","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T12:03:48Z","timestamp":1567598628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Haemophilia A: health and economic burden of a rare disease in Portugal"],"prefix":"10.1186","volume":"14","author":[{"given":"Andreia","family":"Caf\u00e9","sequence":"first","affiliation":[]},{"given":"Manuela","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Crato","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Faria","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Kjollerstrom","sequence":"additional","affiliation":[]},{"given":"Cristina","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia R.","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Ram\u00f3n","family":"Salvado","sequence":"additional","affiliation":[]},{"given":"Alexandra Aires","family":"dos Santos","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,9,4]]},"reference":[{"issue":"2","key":"1175_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1538-7836.2008.03246.x","volume":"7","author":"C Costa","year":"2009","unstructured":"Costa C, Frances AM, Letourneau S, Girodon-Boulandet E, Goossens M. Mosaicism in men in hemophilia: is it exceptional? Impact on genetic counselling. J Thromb Haemost. 2009;7(2):367\u20139 Available from: \n                    http:\/\/doi.wiley.com\/10.1111\/j.1538-7836.2008.03246.x\n                    \n                  . [cited 2019 Apr 24].","journal-title":"J Thromb Haemost"},{"issue":"23","key":"1175_CR2","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJM200106073442307","volume":"344","author":"PM Mannucci","year":"2001","unstructured":"Mannucci PM, Tuddenham EGD. The Hemophilias \u2014 from Royal Genes to gene therapy. N Engl J Med. 2001;344(23):1773\u20139 Available from: \n                    http:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJM200106073442307\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"9824","key":"1175_CR3","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/S0140-6736(11)61139-2","volume":"379","author":"E Berntorp","year":"2012","unstructured":"Berntorp E, Shapiro AD. Modern haemophilia care. Lancet. 2012;379(9824):1447\u201356 Available from: \n                    https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673611611392\n                    \n                  .","journal-title":"Lancet"},{"issue":"1","key":"1175_CR4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/asheducation.V2012.1.362.3798344","volume":"2012","author":"G Young","year":"2012","unstructured":"Young G. New challenges in hemophilia: long-term outcomes and complications. Hematol Am Soc Hematol Educ Progr. 2012;2012(1):362\u20138 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23233605\n                    \n                  . [cited 2019 Apr 24].","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"issue":"3","key":"1175_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1365-2516.2010.02435.x","volume":"17","author":"R Klamroth","year":"2011","unstructured":"Klamroth R, Pollmann H, Hermans C, Faradji A, Yarlas AS, Epstein JD, et al. The relative burden of haemophilia A and the impact of target joint development on health-related quality of life: results from the ADVATE Post-Authorization Safety Surveillance (PASS) study. Haemophilia. 2011;17(3):412\u201321 Available from: \n                    http:\/\/doi.wiley.com\/10.1111\/j.1365-2516.2010.02435.x\n                    \n                  .","journal-title":"Haemophilia"},{"key":"1175_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1365-2516.1999.00213.x","volume":"5","author":"N Saviolo-Negrin","year":"1999","unstructured":"Saviolo-Negrin N, Cristante F, Zanon E, Canclini M, Stocco D, Girolami A. Psychological aspects and coping of parents with a haemophilic child: a quantitative approach. Haemophilia. 1999;5:63\u20138.","journal-title":"Haemophilia"},{"issue":"1","key":"1175_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1365-2516.2010.02280.x","volume":"17","author":"A Coppla","year":"2011","unstructured":"Coppla A, Cerbone AM, Mancuso G, Mansueto MF, Mazzini C, Zanon E. Confronting the psychological burden of haemophilia. Haemophilia. 2011;17(1):21\u20137 Available from: \n                    http:\/\/doi.wiley.com\/10.1111\/j.1365-2516.2010.02280.x\n                    \n                  .","journal-title":"Haemophilia"},{"issue":"3","key":"1175_CR8","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1182\/blood-2006-10-050435","volume":"110","author":"SC Darby","year":"2007","unstructured":"Darby SC, Kan SW, Spooner RJ, Giangrande PLF, Hill FGH, Hay CRM, et al. Mortality rates, life expectancy, and causes of death in people with hemophilia a or B in the United Kingdom who were not infected with HIV. Blood. 2007;110(3):815\u201325 Available from: \n                    http:\/\/www.bloodjournal.org\/cgi\/doi\/10.1182\/blood-2006-10-050435\n                    \n                  .","journal-title":"Blood"},{"issue":"1","key":"1175_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1750-1172-7-24","volume":"7","author":"M Franchini","year":"2012","unstructured":"Franchini M, Mannucci P. Past, present and future of hemophilia: a narrative review. Orphanet J Rare Dis. 2012;7(1):24 Available from: \n                    http:\/\/www.ojrd.com\/content\/7\/1\/24\n                    \n                  . [cited 2018 Jul 25].","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"1175_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1046\/j.1365-2516.2003.00779.x","volume":"9","author":"S Paisley","year":"2003","unstructured":"Paisley S, Wight J, Currie E, Knight C. The management of inhibitors in haemophilia A: introduction and systematic review of current practice. Haemophilia. 2003;9(4):405\u201317 Available from: \n                    http:\/\/doi.wiley.com\/10.1046\/j.1365-2516.2003.00779.x\n                    \n                  .","journal-title":"Haemophilia"},{"issue":"1","key":"1175_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/2040620712464509","volume":"4","author":"C Witmer","year":"2013","unstructured":"Witmer C, Young G. Factor VIII inhibitors in hemophilia a: rationale and latest evidence. Ther Adv Hematol. 2013;4(1):59\u201372 Available from: \n                    http:\/\/journals.sagepub.com\/doi\/10.1177\/2040620712464509\n                    \n                  .","journal-title":"Ther Adv Hematol"},{"issue":"1","key":"1175_CR12","doi-asserted-by":"publisher","first-page":"069","DOI":"10.1055\/s-2003-37941","volume":"29","author":"G Mariani","year":"2003","unstructured":"Mariani G, Siragusa S, Kroner BL. Immune tolerance induction in hemophilia a: a review. Semin Thromb Hemost. 2003;29(1):069\u201376 Available from: \n                    http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-2003-37941\n                    \n                  . [cited 2018 Jul 25].","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"1175_CR13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s12913-015-1134-3","volume":"15","author":"P Rocha","year":"2015","unstructured":"Rocha P, Carvalho M, Lopes M, Ara\u00fajo F. Costs and utilization of treatment in patients with hemophilia. BMC Health Serv Res. 2015;15(1):484 Available from: \n                    http:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-015-1134-3\n                    \n                  .","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"1175_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11096-007-9181-4","volume":"30","author":"V Nerich","year":"2008","unstructured":"Nerich V, Tissot E, Faradji A, Demesmay K, Bertrand MA, Lorenzini J-L, et al. Cost-of-illness study of severe haemophilia A and B in five French haemophilia treatment centres. Pharm World Sci. 2008;30(3):287\u201392 Available from: \n                    http:\/\/link.springer.com\/10.1007\/s11096-007-9181-4\n                    \n                  .","journal-title":"Pharm World Sci"},{"key":"1175_CR15","first-page":"1","volume":"684","author":"SA Larsson","year":"1984","unstructured":"Larsson SA. Hemophilia in Sweden. Studies on demography of hemophilia and surgery in hemophilia and von Willebrand\u2019s disease. Acta Med Scand Suppl. 1984;684:1\u201372.","journal-title":"Acta Med Scand Suppl"},{"key":"1175_CR16","first-page":"s126","volume":"22","author":"S-L Chen","year":"2016","unstructured":"Chen S-L. Economic costs of hemophilia and the impact of prophylactic treatment on patient management. Am J Manag Care. 2016;22:s126\u201333.","journal-title":"Am J Manag Care"},{"key":"1175_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2516.2005.01153.x","volume":"11","author":"C Knight","year":"2005","unstructured":"Knight C. Health economics of treating haemophilia A with inhibitors. Haemophilia. 2005;11:11\u20137.","journal-title":"Haemophilia"},{"issue":"1","key":"1175_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13023-017-0660-y","volume":"12","author":"J O\u2019Hara","year":"2017","unstructured":"O\u2019Hara J, Hughes D, Camp C, Burke T, Carroll L, D-AG D. The cost of severe haemophilia in Europe: the CHESS study. Orphanet J Rare Dis. 2017;12(1):106 Available from: \n                    http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-017-0660-y\n                    \n                  .","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1175_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1172-9-39","volume":"9","author":"S Henrard","year":"2014","unstructured":"Henrard S, Devleesschauwer B, Beutels P, Callens M, De Smet F, Hermans C, et al. The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease. Orphanet J Rare Dis. 2014;9(1):39 Available from: \n                    http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-9-39\n                    \n                  .","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"1175_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3111\/13696998.2015.1016228","volume":"18","author":"Z-Y Zhou","year":"2015","unstructured":"Zhou Z-Y, Koerper MA, Johnson KA, Riske B, Baker JR, Ullman M, et al. Burden of illness: direct and indirect costs among persons with hemophilia a in the United States. J Med Econ. 2015;18(6):457\u201365 Available from: \n                    https:\/\/cloudfront.escholarship.org\/dist\/prd\/content\/qt5d79b9fc\/qt5d79b9fc.pdf?t=nw6jjx\n                    \n                  . [cited 2019 Apr 26].","journal-title":"J Med Econ"},{"key":"1175_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2516.2004.00950.x","volume":"10","author":"G Auerswald","year":"2004","unstructured":"Auerswald G, von Depka Prondzinski M, Ehlken B, Kreuz W, Kurnik K, Lenk H, et al. Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in Germany. Haemophilia. 2004;10:499\u2013508.","journal-title":"Haemophilia"},{"issue":"S1","key":"1175_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10198-016-0785-2","volume":"17","author":"M Cavazza","year":"2016","unstructured":"Cavazza M, Kodra Y, Armeni P, De Santis M, L\u00f3pez-Bastida J, Linertov\u00e1 R, et al. Social\/economic costs and quality of life in patients with haemophilia in Europe. Eur J Health Econ. 2016;17(S1):53\u201365 Available from: \n                    http:\/\/link.springer.com\/10.1007\/s10198-016-0785-2\n                    \n                  . [cited 2019 Apr 26].","journal-title":"Eur J Health Econ"},{"issue":"4","key":"1175_CR23","doi-asserted-by":"publisher","first-page":"S482","DOI":"10.1016\/j.amepre.2009.12.016","volume":"38","author":"A-A Siddiqi","year":"2010","unstructured":"Siddiqi A-A, Ebrahim SH, Soucie JM, Parker CS, Atrash HK. Burden of disease resulting from hemophilia in the U.S. Am J Prev Med. 2010;38(4):S482\u20138 Available from: \n                    https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379709009453\n                    \n                  . [cited 2019 Apr 26].","journal-title":"Am J Prev Med"},{"key":"1175_CR24","volume-title":"Di\u00e1rio da Rep\u00fablica n.o 60\/2018, 1o Suplemento, S\u00e9rie II de 2018-03-26","author":"Di\u00e1rio da Rep\u00fablica Eletr\u00f3nico","year":"2018","unstructured":"Di\u00e1rio da Rep\u00fablica Eletr\u00f3nico. Di\u00e1rio da Rep\u00fablica n.o 60\/2018, 1o Suplemento, S\u00e9rie II de 2018-03-26. 2018. Available from: \n                    https:\/\/dre.pt\/web\/guest\/home\/-\/dre\/114925355\/details\/maximized?serie=II&dreId=114925353\n                    \n                  . [cited 2019 May 3]"},{"issue":"7001","key":"1175_CR25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","volume":"311","author":"J Jones","year":"1995","unstructured":"Jones J, Hunter D. Qualitative research: consensus methods for medical and health services research. BMJ. 1995;311(7001):376\u201380 Available from: \n                    http:\/\/www.bmj.com\/cgi\/doi\/10.1136\/bmj.311.7001.376\n                    \n                  .","journal-title":"BMJ"},{"key":"1175_CR26","unstructured":"Instituto Nacional de Estat\u00edstica. Popula\u00e7\u00e3o m\u00e9dia anual residente (S\u00e9rie longa, in\u00edcio 1971 - N.o) por Sexo e Idade. Available from: \n                    https:\/\/www.ine.pt\/xportal\/xmain?xpid=INE&xpgid=ine_indicadores&indOcorrCod=0001223&contexto=bd&selTab=tab2&xlang=pt\n                    \n                  . [cited 2019 May 25]"},{"issue":"01","key":"1175_CR27","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1055\/s-0038-1624568","volume":"02","author":"PR Pinto","year":"2018","unstructured":"Pinto PR, Paredes AC, Pedras S, Costa P, Crato M, Fernandes S, et al. Sociodemographic, clinical, and psychosocial characteristics of people with hemophilia in Portugal: findings from the first National Survey. TH Open. 2018;02(01):e54\u201367. \n                    https:\/\/doi.org\/10.1055\/s-0038-1624568\n                    \n                  .","journal-title":"TH Open"},{"key":"1175_CR28","volume-title":"Taxa de desemprego: total e por sexo","author":"PORDATA","year":"2017","unstructured":"PORDATA. Taxa de desemprego: total e por sexo. 2017. Available from: \n                    https:\/\/www.pordata.pt\/Portugal\/Taxa+de+desemprego+total+e+por+sexo+(percentagem)-550-3169\n                    \n                  . [cited 2019 Jul 5]"},{"key":"1175_CR29","unstructured":"SPMS - Servi\u00e7os Partilhados do Minist\u00e9rio da Sa\u00fade. Cat\u00e1logo de Aprovisionamento P\u00fablico da Sa\u00fade. Available from: \n                    https:\/\/www.catalogo.min-saude.pt\/CEC\/Publico\/Default.aspx\n                    \n                  . [cited 2017 Oct 31]"},{"key":"1175_CR30","unstructured":"Autoridade Nacional do Medicamento e Produtos de Sa\u00fade I.P. Infomed - Pesquisa de Medicamentos. Available from: \n                    http:\/\/app7.infarmed.pt\/infomed\/pesquisa.php\n                    \n                  . [cited 2017 Oct 31]"},{"key":"1175_CR31","unstructured":"Di\u00e1rio da Rep\u00fablica, 1\u00aa s\u00e9rie - N\u00ba 132 - 11 de julho de 2017. Portaria no 207\/2017. Available from:\u00a0\n                    https:\/\/dre.pt\/application\/conteudo\/107669157\n                    \n                  . [cited 2018 Jul 26]."},{"key":"1175_CR32","unstructured":"Di\u00e1rio da Rep\u00fablica, 2\u00aa s\u00e9rie - N\u00ba 108 - 4 de junho de 2012. Despacho n.o7702-A\/2012. Available from:\u00a0\n                    https:\/\/dre.pt\/application\/conteudo\/3560102\n                    \n                  . [cited 2018 Jul 26]."},{"key":"1175_CR33","unstructured":"Di\u00e1rio da Rep\u00fablica, 1\u00aa s\u00e9rie - N\u00ba 94 - 15 de maio de 2012. Portaria n.o142-B\/2012. Available from:\u00a0\n                    https:\/\/dre.pt\/application\/conteudo\/572591\n                    \n                  . [cited 2018 Jul 26]."},{"key":"1175_CR34","unstructured":"Economias. Ajudas de custo em 2018. Available from: \n                    https:\/\/www.economias.pt\/ajudas-de-custo\/\n                    \n                  . [cited 2018 Jul 26]"},{"issue":"5","key":"1175_CR35","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1590\/S0034-8910.2013047004598","volume":"47","author":"J Perelman","year":"2013","unstructured":"Perelman J, Alves J, Miranda AC, Mateus C, Mansinho K, Antunes F, et al. Direct treatment costs of HIV\/AIDS in Portugal. Rev Saude Publica. 2013;47(5):865\u201372 Available from: \n                    http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0034-89102013000500865&lng=en&tlng=en\n                    \n                  . [cited 2019 Apr 24].","journal-title":"Rev Saude Publica"},{"key":"1175_CR36","unstructured":"Marlene Carri\u00e7o. Governo chega a acordo com farmac\u00eauticas para tratar 15 mil doentes com Hepatite C - Observador. Available from: \n                    https:\/\/observador.pt\/2017\/02\/17\/governo-chega-a-acordo-com-farmaceuticas-para-tratar-15-mil-doentes-com-hepatite-c\/\n                    \n                  . [cited 2017 Oct 31]"},{"key":"1175_CR37","volume-title":"Ganho M\u00e9dio Mensal","author":"Instituto Nacional de Estat\u00edstica","year":"2017","unstructured":"Instituto Nacional de Estat\u00edstica. Ganho M\u00e9dio Mensal 2017. Available from: \n                    https:\/\/www.ine.pt\/xportal\/xmain?xpid=INE&xpgid=ine_indicadores&indOcorrCod=0006914&contexto=bd&selTab=tab2\n                    \n                  . [cited 2017 Oct 22]"},{"key":"1175_CR38","volume-title":"Portal das Finan\u00e7as - Descri\u00e7\u00e3o Tabelas de Reten\u00e7\u00e3o do IRS","author":"Autoridade Tribut\u00e1ria e Aduaneira","year":"2017","unstructured":"Autoridade Tribut\u00e1ria e Aduaneira. Portal das Finan\u00e7as - Descri\u00e7\u00e3o Tabelas de Reten\u00e7\u00e3o do IRS 2017. Available from: \n                    http:\/\/info.portaldasfinancas.gov.pt\/pt\/apoio_contribuinte\/tabela_ret_doclib\/Pages\/default.aspx\n                    \n                  . [cited 2017 Oct 22]"},{"key":"1175_CR39","unstructured":"World Health Organization. WHO | Metrics: Disability-Adjusted Life Year (DALY): World Health Organization; 2014. Available from: \n                    https:\/\/www.who.int\/healthinfo\/global_burden_disease\/metrics_daly\/en\/\n                    \n                  .. [cited 2017 Oct 22]"},{"key":"1175_CR40","unstructured":"PORDATA. Taxa bruta de mortalidade. Available from: \n                    https:\/\/www.pordata.pt\/Europa\/Taxa+bruta+de+mortalidade-1941\n                    \n                  . [cited 2019 May 26]."},{"issue":"9","key":"1175_CR41","doi-asserted-by":"publisher","first-page":"e0162478","DOI":"10.1371\/journal.pone.0162478","volume":"11","author":"M Ock","year":"2016","unstructured":"Ock M, Ahn J, Yoon S-J, Jo M-W. Estimation of disability weights in the general population of South Korea using a paired comparison. Sankoh OA, editor. PLoS One. 2016;11(9):e0162478 Available from: \n                    http:\/\/dx.plos.org\/10.1371\/journal.pone.0162478\n                    \n                  .","journal-title":"PLoS One"},{"issue":"9859","key":"1175_CR42","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/S0140-6736(12)61680-8","volume":"380","author":"JA Salomon","year":"2012","unstructured":"Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the global burden of disease study 2010. Lancet. 2012;380(9859):2129\u201343 Available from: \n                    https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673612616808\n                    \n                  .","journal-title":"Lancet"},{"issue":"4","key":"1175_CR43","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/hae.12341","volume":"20","author":"AM Carvalhosa","year":"2014","unstructured":"Carvalhosa AM, Henrard S, Lambert C, Hermans C. Physical and mental quality of life in adult patients with haemophilia in Belgium: the impact of financial issues. Haemophilia. 2014;20(4):479\u201385 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24354566\n                    \n                  . [cited 2019 Jun 27].","journal-title":"Haemophilia"},{"issue":"12","key":"1175_CR44","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/hec.1823","volume":"21","author":"Bernard van den Berg","year":"2012","unstructured":"Bernard van den Berg. SF-6D POPULATION NORMS. Health Economics. 2012;21(12):1508\u20131512.","journal-title":"Health Economics"},{"key":"1175_CR45","unstructured":"World Health Organization. WHO | National tools: World Health Organization; 2014. Available from: \n                    https:\/\/www.who.int\/healthinfo\/global_burden_disease\/tools_national\/en\/\n                    \n                  . [cited 2017 Oct 22]"},{"key":"1175_CR46","unstructured":"PORDATA. Nados-vivos de m\u00e3es residentes em Portugal: total e por sexo 2017. Available from: \n                    https:\/\/www.pordata.pt\/MicroPage.aspx?\n                    \n                   DatabaseName=Municipios&MicroName=Nados+vivos+de+m\u00e3es+residentes+em+Portugal+total+e+por+sexo-103&MicroURL=444&. [cited 2017 Oct 16]"},{"key":"1175_CR47","unstructured":"PORDATA. Esperan\u00e7a de vida \u00e0 nascen\u00e7a: total e por sexo 2017. Available from: \n                    https:\/\/www.pordata.pt\/MicroPage.aspx?\n                    \n                   DatabaseName=Europa&MicroName=Esperan\u00e7a+de+vida+\u00e0+nascen\u00e7a+total+e+por+sexo&MicroURL=1260&. [cited 2017 Oct 22]"},{"key":"1175_CR48","volume-title":"Despesa em cuidados de sa\u00fade por habitante (Euro)","author":"PORDATA","year":"2016","unstructured":"PORDATA. Despesa em cuidados de sa\u00fade por habitante (Euro). 2016. Available from: \n                    https:\/\/www.pordata.pt\/Europa\/Despesa+em+cuidados+de+sa\u00fade+por+habitante+(Euro)-1963\n                    \n                  . [cited 2019 Apr 30]"},{"key":"1175_CR49","volume-title":"Popula\u00e7\u00e3o residente","author":"Instituto Nacional de Estat\u00edstica","year":"2017","unstructured":"Instituto Nacional de Estat\u00edstica. Popula\u00e7\u00e3o residente 2017. Available from: \n                    https:\/\/www.ine.pt\/xportal\/xmain?xpid=INE&xpgid=ine_indicadores&indOcorrCod=0001223&contexto=bd&selTab=tab2&xlang=pt\n                    \n                  . [cited 2019 Apr 30]"},{"key":"1175_CR50","unstructured":"World Federation of Hemophilia Report on the Annual Global Survey 2015. Montr\u00e9al; 2015. Available from: \n                    http:\/\/www1.wfh.org\/publications\/files\/pdf-1669.pdf\n                    \n                  . [cited 2018 Jul 25]"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1175-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1175-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1175-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T23:08:50Z","timestamp":1599088130000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1175-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,4]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1175"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1175-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,4]]},"assertion":[{"value":"20 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors state that there is no financial or personal relationship with other individuals or entities which may influence their work inappropriately. AC is a full-time employee of Roche.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"211"}}